Biokin Pharmaceutical Co., Ltd Eyes Secondary Listing on HKEX, Co-Sponsored by Goldman Sachs and Others
Sichuan Biokin Pharmaceutical Co., Ltd (SHA: 688506), a company listed on the Shanghai Stock Exchange’s...
Allist Pharmaceuticals Faces Arbitration Over Promotion Agreement for Furmonertinib
Allist Pharmaceuticals Co., Ltd, a Shanghai-based biopharmaceutical company, has announced that it has received a...
Bayer Restructures China Business into Five Sectors and Six Departments
Bayer (ETR: BAYN), the German pharmaceutical and life sciences giant, has announced a strategic restructuring...
Digital Health China Partners with Huawei to Launch Intelligent Multimodal Big Data System for Healthcare
Digital Health China Technologies Co., Ltd., a leading cloud-based healthcare service provider based in China,...
Pfizer and AbbVie Announce Leadership Changes in Global R&D Divisions
In significant executive reshuffling, Pfizer Inc. (NYSE: PFE) and AbbVie (NYSE: ABBV) have both announced...
Pfizer Collaborates with Evotec for Drug Candidates in Metabolic and Infectious Diseases
Pfizer Inc. (NYSE: PFE) has entered into a multi-year collaboration with Germany-based biotechnology company Evotec...
Novo Nordisk Partners with Indonesia’s Bio Farma to Boost Asia-Pacific Diabetes Drug Production
Novo Nordisk (NYSE: NVO; CPH: NOVO-B), the Danish pharmaceutical giant specializing in diabetes care, is...
Abbisko Therapeutics Forecasts Profits and Revenue Boost in H1 2024 on Merck Deal
Abbisko Therapeutics Co., Ltd (HKG: 2256), a Shanghai-based biotechnology company, has released a positive financial...
Junshi Biosciences’ Subsidiary Secures EU GMP Certification, Strengthening Loqtorzi’s Market Prospects
Shanghai Junshi Biosciences Co., Ltd (HKG: 1877; SHA: 688180), a leading biopharmaceutical company based in...
AFT Pharmaceuticals Partners with Hainan Haiyao for Distribution of Crystaderm Cream in China
AFT Pharmaceuticals (JSE: AFT, ASX: ASX), a company based in New Zealand, has announced an...
Amgen Halts Development of Claudin 6-Targeting BiTE Immune Therapy AMG 794
Amgen Inc. (NASDAQ: AMGN), a leading biopharmaceutical company based in the U.S., has decided to...
Kymera Therapeutics’ Stock Soars on Sanofi’s Plans to Expand KT-474 Clinical Trials
Kymera Therapeutics Inc. (NASDAQ: KYMR), a biopharmaceutical company based in the U.S., has announced that...
BGI Genomics’ Subsidiary Inks 3-Year Noninvasive Prenatal Test Agreement with Heilongjiang Province
BGI Genomics Co., Ltd (SHE: 300676), a leading genomics company based in China, has announced...
Shanghai Vitalgen BioPharma Launches Phase I/II Gene Therapy Trial for Parkinson’s Disease
Shanghai Vitalgen BioPharma Co., Ltd, a biopharmaceutical company based in China, has initiated a Phase...
Kintor Pharmaceutical Launches Global Cosmetic Line with Hair Loss Treatment Pyrilutamide
Kintor Pharmaceutical Ltd (HKG: 9939), a biopharmaceutical company based in China, has announced the global...
Suzhou Sanegene Bio Receives NMPA Approval for Clinical Trial of Antihypertensive siRNA Drug
Suzhou Sanegene Bio Inc., a leading RNAi specialist with research and development centers in both...
Shanghai Junshi Biosciences’ HDAC Inhibitor JS125 Clinical Trial Application Accepted by NMPA
Shanghai Junshi Biosciences Co., Ltd (HKG: 1877; SHA: 688180) has announced that the National Medical...
Johnson & Johnson’s Opsumit Faces Generic Competition with Qilu Pharmaceutical’s Entry
Johnson & Johnson (J&J, NYSE: JNJ)’s pulmonary hypertension treatment, Opsumit (macitentan), is set to encounter...
China Isotope & Radiation Corporation Secures NMPA License for Innovative Radiotherapy System
China Isotope & Radiation Corporation (CIRC; HKG: 1763) has announced that it has received a...
Staidson Pharmaceutical Gets NMPA Green Light for Neurotrophic Keratitis Eye Drop Clinical Trial
Staidson (Beijing) Pharmaceutical Co., Ltd (SHE: 300204), a biopharmaceutical company based in China, has announced...